Drug Pipeline

Ofatumumab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
13
Active Studies
5
Recruiting
3
Phase 3
9
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-04 NCT07625800 Switch to Ofatumumab and Level of Immunoglobulins Not Yet Recruiting
Active Studies by Phase
Phase 4
1
Phase 3
3
Phase 2
2
Phase 1/2
1
Early Phase 1
1
Not specified
5
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05090371 A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After… Relapsing-Remitting Multiple Sclerosis Active, Not Recruiting
Phase 3
NCT06867991 Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune… Anti-N-Methyl-D-Aspartate Receptor Encephalitis Recruiting
NCT04926818 Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric… Multiple Sclerosis (MS) Active, Not Recruiting
NCT03650114 Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With… Relapsing Multiple Sclerosis Active, Not Recruiting
Phase 2
NCT03136146 Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute… Recurrent Acute Lymphoblastic Leukemia Recruiting
NCT02877303 Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in… B Acute Lymphoblastic Leukemia Recruiting
Phase 1/2
NCT05504694 Ofatumumab in AQP4-IgG Seropositive NMOSD Neuromyelitis Optica Spectrum Disorder Recruiting
Early Phase 1
NCT07546110 An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy… Multiple Sclerosis Not Yet Recruiting
Not specified
NCT07353216 Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple… Multiple Sclerosis Recruiting
NCT06345157 ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS… Multiple Sclerosis, Relapsing-Remitting Active, Not Recruiting
NCT05688436 A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants… Multiple Sclerosis Active, Not Recruiting
NCT07625800 Switch to Ofatumumab and Level of Immunoglobulins Multiple Sclerosis Not Yet Recruiting
NCT06167642 Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking… Multiple Sclerosis Enrolling by Invitation
Sponsors Running Ofatumumab Trials
Disease Areas
Get alerts when Ofatumumab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free